Static Chart PROCEPT BioRobotics Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 15:22:39 16/05/2024 BST			5-day change	1st Jan Change
68 ^USD	-1.72%		+8.25%	+62.73%

05-06	Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating	MT
05-06	PROCEPT BioRobotics Corporation Announces Long-Term, Real-World Data Showing the Benefits of Aquablation Therapy for the Treatment of Symptomatic Prostatic Hyperplasia	CI

Duration

Period